SREBF2 and neuroblastoma: There have been no studies in human NCC to demonstrate that they are capable of cholesterol biosynthesis, however, transcriptional profiling of aggressive mouse and human neuroblastoma cells, a NCC-derived malignancy, have demonstrated increased cholesterol biosynthesis driven by the transcription factor sterol regulatory-element binding protein-2 (SREBP-2)26.